
6.10 Delayed Data As of 4:00pm ET | ![]() Today’s Change | 3.43 Today|||52-Week Range 8.22 | -3.33% Year-to-Date |
SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $185.6M |
Catalyst Biosciences, Inc. 611 Gateway Boulevard South San Francisco California 94080 |
Nassim Usman | President, Chief Executive Officer & Director |
Clinton Musil | Chief Financial Officer |
Howard Levy | Chief Medical Officer |
Andrew Hetherington | Senior Vice President-Technical Operations |
Linda Neuman | Vice President-Clinical Development |